Paradigm Capital Management Inc. NY Cuts Stock Position in Viemed Healthcare, Inc. $VMD

Key Points

• Paradigm Capital Management Inc. significantly reduced its stake in Viemed Healthcare by 66.7%, selling 100,000 shares and retaining 50,000, which are valued at $364,000.
• Insider trading activity includes Viemed's President Michael Moore selling 50,090 shares at $7.33, resulting in a 28.39% decrease in his ownership.
• Viemed Healthcare recently reported earnings of $0.08 per share, meeting analysts' expectations, but revenue fell slightly short at $63.06 million against an expectation of $63.50 million.

Paradigm Capital Management Inc. NY decreased its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 66.7% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 50,000 shares of the company's stock after selling 100,000 shares during the period. Paradigm Capital Management Inc. NY owned approximately 0.13% of Viemed Healthcare worth $364,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Millennium Management LLC bought a new stake in shares of Viemed Healthcare in the 4th quarter worth about $573,000. Ameriprise Financial Inc. bought a new stake in shares of Viemed Healthcare in the 4th quarter worth about $340,000. Nuveen Asset Management LLC lifted its holdings in shares of Viemed Healthcare by 22.1% in the 4th quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock worth $1,301,000 after acquiring an additional 29,320 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Viemed Healthcare by 1.8% in the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock worth $2,300,000 after acquiring an additional 5,090 shares during the last quarter. Finally, Deutsche Bank AG lifted its holdings in Viemed Healthcare by 2,891.5% during the 4th quarter. Deutsche Bank AG now owns 23,214 shares of the company's stock valued at $186,000 after buying an additional 22,438 shares in the last quarter. Institutional investors own 74.24% of the company's stock.

Insider Activity

In related news, President Michael Moore sold 50,090 shares of the business's stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $7.33, for a total value of $367,159.70. Following the completion of the transaction, the president owned 126,343 shares of the company's stock, valued at $926,094.19. The trade was a 28.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Nitin Kaushal sold 34,100 shares of the business's stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00. Following the completion of the transaction, the director directly owned 126,843 shares of the company's stock, valued at $889,169.43. This trade represents a 21.19% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 97,922 shares of company stock worth $703,886. Company insiders own 20.00% of the company's stock.

Viemed Healthcare Trading Down 0.1%

VMD traded down $0.01 on Wednesday, reaching $6.80. 243,684 shares of the company traded hands, compared to its average volume of 314,735. The firm has a fifty day simple moving average of $6.80 and a two-hundred day simple moving average of $6.95. The company has a quick ratio of 1.37, a current ratio of 1.48 and a debt-to-equity ratio of 0.02. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $9.81. The company has a market cap of $263.77 million, a P/E ratio of 21.68 and a beta of 1.38.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.08. The firm had revenue of $63.06 million during the quarter, compared to analyst estimates of $63.50 million. Viemed Healthcare had a return on equity of 10.38% and a net margin of 5.80%.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.